Beta Bionics, Inc.
Beta Bionics, Inc. (BBNX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BBNX · as of Jun 8, 2026
Key Statistics
Explore Beta Bionics, Inc. Data
bbnx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 8 · Buy rate: 75.0%
The BBNX analyst consensus is Buy, based on ratings from 8 Wall Street analysts over the past 3 months. The average 12-month price target is $19.86, representing +39.47% upside from the current price of $14.24.
Competitors & Peers
bbnx competitorsBBNX
AHCO
DVAX
IMTX
KMTS
ORICStock Performance
Full HistoryAbout Beta Bionics, Inc.
Beta Bionics, Inc. a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring peo…
what is beta bionics, inc. · bbnx stock overview · beta bionics, inc. company profile · who is beta bionics, inc. ceo · bbnx NASDAQ · beta bionics, inc. headquarters · beta bionics, inc. business segments
About Stock Overview & Key Data
Beta Bionics, Inc. (BBNX) is a Healthcare company in the Medical - Equipment & Services industry, listed on NASDAQ since Jan 30, 2025. As of the latest trading session, BBNX stock price is $14.24, with a market capitalization of $634.5M. The stock has returned -28.44% over the past 12 months and -54.41% year-to-date.
According to 8 Wall Street analysts, the consensus rating for Beta Bionics, Inc. stock is Buy, with an average 12-month price target of $19.86. In fiscal year 2025, Beta Bionics, Inc. reported revenue of $100.3M and net income of -$73.2M. For detailed data — including Beta Bionics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Beta Bionics, Inc. (BBNX) stock price is $14.24. The stock is traded on NASDAQ under the ticker symbol BBNX. The 52-week range is $8.80 – $32.71.